Nov 2023 - The FDA's approval of Eli Lillys Zepbound (tirzepatide) represents a significant advancement in obesity treatment, as it uniquely targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
Table 2 [i] The adjusted mean differences and p-values were calculated using multiple linear regression analyses with adjustment for age, physical activity, alcohol intake, body mass index, estimated glomerular filtration rate, diabetes, hypertension, and dyslipidemia

[9] To get Wegovy approved, you must meet all of: A 6-month weight-management program first documented behavioral modification, reduced-calorie diet, and increased physical activity with continuing follow-up (this is the real hurdle, not another drug) BMI 30 , or 27 with a weight-related condition (hypertension, type 2 diabetes, or dyslipidemia) Age 18+ (ages 1217 require the injection plus the comprehensive program) No drug step therapy: CVS Caremark's standard Wegovy policy does not require trying and failing another weight-loss drug first (some individual employer plans add it check yours) Wegovy also has separate coverage pathways for cardiovascular risk reduction (established heart disease + BMI 27, if you don't have type 2 diabetes) and MASH liver disease
262 Additionally, KD was shown to enhance radiation sensitivity in a pancreatic cancer xenograft model, suggesting potential improvements in therapeutic outcomes
Keep in mind this is one marker, and lowering it has not by itself been proven to prevent heart attacks or strokes
[73] International operations expanded even further during World War II